Oxalatoplatin
Categoria
Oxalatoplatin Nombres de marca, Oxalatoplatin Analogos
Oxalatoplatin Marca los nombres de mezcla
Oxalatoplatin Formula quimica
Oxalatoplatin RX enlace
Oxalatoplatin FDA hoja
Oxalatoplatin MSDS (hoja de seguridad de materiales)
Oxalatoplatin Sintesis de referencia
Oxalatoplatin Peso molecular
Oxalatoplatin Punto de fusion
Oxalatoplatin H2O Solubilidad
Oxalatoplatin Estado
Oxalatoplatin LogP
Oxalatoplatin Formas de dosificacion
Oxalatoplatin Indicacion
Oxalatoplatin Farmacologia
Oxalatoplatin Absorcion
Oxalatoplatin Toxicidad
Oxalatoplatin Informacion de Pacientes
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
